Abstract:RNA editing offers the opportunity to introduce either stable or transient modifications to nucleic acid sequence without permanent off-target effects, but installation of arbitrary edits into the transcriptome is currently infeasible. Here, we describe Programmable RNA Editing & Cleavage for Insertion, Substitution, and Erasure (PRECISE), a versatile RNA editing method for writing RNA of arbitrary length and sequence into existing pre-mRNAs via 5′ or 3′ trans-splicing. In trans-splicing, an exogenous template is introduced to compete with the endogenous pre-mRNA, allowing for replacement of upstream or downstream exon sequence. Using Cas7-11 cleavage of pre-mRNAs to bias towards editing outcomes, we boost the efficiency of RNA trans-splicing by 10–100 fold, achieving editing rates between 5–50% and 85% on endogenous and reporter transcripts, respectively, while maintaining high-fidelity. We demonstrate PRECISE editing across 11 distinct endogenous transcripts of widely varying expression levels, showcasing more than 50 types of edits, including all 12 possible transversions and transitions, insertions ranging from 1 to 1,863 nucleotides, and deletions. We show high efficiency replacement of exon 4 of MECP2, addressing most mutations that drive the Rett Syndrome; editing of SHANK3 transcripts, a gene involved in Autism; and replacement of exon 1 of HTT, removing the hallmark repeat expansions of Huntington′s disease. Whole transcriptome sequencing reveals the high precision of PRECISE editing and lack of off-target trans-splicing activity. Furthermore, we combine payload engineering and ribozymes for protein-free, high-efficiency trans-splicing, with demonstrated efficiency in editing HTT exon 1 via AAV delivery. We show that the high activity of PRECISE editing enables editing in non-dividing neurons and patient-derived Huntington’s disease fibroblasts. PRECISE editing markedly broadens the scope of genetic editing, is straightforward to deliver over existing gene editing tools like prime editing, lacks permanent off-targets, and can enable any type of genetic edit large or small, including edits not otherwise possible with existing RNA base editors, widening the spectrum of addressable diseases.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is that the existing RNA - editing techniques are unable to perform highly efficient and precise editing on RNAs of any length and sequence in the transcriptome. Specifically, current RNA - editing techniques can only achieve limited base conversions (such as A to I or C to U), and are unable to achieve the other ten possible base conversions and transversions, nor can they achieve small - scale or large - scale insertions or deletions. These problems limit the scope of RNA - editing applications in the treatment of genetic diseases. To overcome these limitations, the authors developed a new method named "Programmable RNA Editing & Cleavage for Insertion, Substitution, and Erasure (PRECISE)". PRECISE utilizes the precise cutting ability of the CRISPR - Cas7 - 11 nuclease and introduces exogenous templates into cells through 5' or 3' trans - splicing techniques, thereby achieving RNA editing of any length and sequence of the target pre - mRNA. This method can not only achieve all twelve possible single - base conversions and transversions, but also achieve large - scale insertions and deletions from 1 nucleotide to 1,863 nucleotides, and has high efficiency and high fidelity. The main contributions of the paper are as follows: 1. **Extensive editing ability**: PRECISE can achieve all types of single - base editing, including all conversions and transversions, as well as insertions and deletions of any size. 2. **Efficient editing efficiency**: By optimizing the catalytic activity of Cas7 - 11 and the design of RNA templates, PRECISE has achieved an editing efficiency of up to 85% in multiple cell types. 3. **Low off - target effects**: Through whole - transcriptome sequencing, the authors have demonstrated that PRECISE editing has high precision and almost no off - target effects. 4. **Applicable to multiple cell types**: PRECISE editing is not only effective in HEK293FT cells, but also shows high - efficiency editing ability in non - dividing neurons and fibroblasts derived from Huntington's disease patients. 5. **Compatible with viral and non - viral delivery systems**: The PRECISE system can be delivered through adeno - associated virus (AAV) or lentivirus, and is suitable for multiple application scenarios. In conclusion, this paper proposes a revolutionary RNA - editing technique, which greatly expands the scope and ability of gene editing and provides new possibilities for the treatment of genetic diseases.

Programmable RNA writing with trans-splicing

Rewriting endogenous human transcripts with -splicing

A Novel Engineered U7 Small Nuclear RNA Scaffold Greatly Increases and ADAR-Mediated Programmable RNA Base Editing

A circularly permuted CasRx platform for efficient, site-specific RNA editing

Robust RNA editing via recruitment of endogenous ADARs using circular guide RNAs

RNA editing with CRISPR-Cas13

Precise in vivo RNA base editing with a wobble-enhanced circular CLUSTER guide RNA

Programmable RNA base editing via targeted modifications

Programmable System of Cas13-Mediated RNA Modification and Its Biological and Biomedical Applications

RNA Exon Editing: Splicing the way to treat human diseases

An improved SNAP-ADAR tool enables efficient RNA base editing to interfere with post-translational protein modification

Precision RNA base editing with engineered and endogenous effectors

RNA editing with CRISPR

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Precise RNA editing by recruiting endogenous ADARs with antisense oligonucleotides

Repurposing CRISPR-Cas13 systems for robust mRNA trans-splicing

CRISPR-Cas13: Pioneering RNA Editing for Nucleic Acid Therapeutics

Precision Transcriptome Editing

A split prime editor with untethered reverse transcriptase and circular RNA template